Skip to Content

Ferrous fumarate Pregnancy and Breastfeeding Warnings

Ferrous fumarate is also known as: Femiron, Feostat, Ferretts Iron, Ferrimin 150, Ferrocite, Fumasorb, Hemocyte, Ircon, Iron Fumarate, Nephro-Fer

Medically reviewed on December 29, 2017

Ferrous fumarate Pregnancy Warnings

Use is considered acceptable.

AU TGA pregnancy category: Exempt
US FDA pregnancy category: Not assigned

Comments:
-Routine screening for anemia, including in asymptomatic patients, is generally recommended.
-Routine supplementation during pregnancy is recommended by many organizations.

Maternal anemia increases the risk of low birthweight, premature delivery, and impaired cognitive and behavioral development. Randomized trials show that supplementation can prevent iron deficiency anemia and related adverse consequences to the infant. Recent studies have linked high serum iron with an increased risk of gestational diabetes.

AU Exempt: Medications exempted from pregnancy classification are not absolutely safe for use in pregnancy in all circumstances. Some exempted medicines, for example the complementary medicine, St John's Wort, may interact with other medicines and induce unexpected adverse effects in the mother and/or fetus.

See references

Ferrous fumarate Breastfeeding Warnings

Use is considered acceptable.

Excreted into human milk: Yes


Comments:
-Iron in breast milk is very bioavailable, but amounts are generally not sufficient for infants older than 4 months; iron supplementation of the mother does not change this situation.
-Iron content of breast milk is not affected by the mothers nutritional status.

See references

References for pregnancy information

  1. World Health Organization (WHO) "Iron Deficiency Anaemia. Assessment, Prevention, and Control, A guide for programme managers Available from: URL: http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf." ([2001]):
  2. Bao W, Chavarro JE, Tobias DK, et.al "Long-term risk of type 2 diabetes in relation to habitual iron intake in women with a history of gestational diabetes: a prospective cohort study." Am J Clin Nutr 103 (2016): 375-81
  3. NIH Office of Dietary Supplements "Iron Dietary Supplement Fact Sheet. Available from: URL: https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/?print=1" ([2016, Feb 01]):
  4. McDonagh M, Cantor A, Bougatsos C, et al. "Routine Iron Supplementation and Screening for Iron Deficiency Anemia in Pregnant Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation [Internet] Available from: URL: https://www.ncbi.nlm.nih.gov/books/NBK285987/" ([2015, Mar]):
  5. Rawal S, Hinkle SN, Bao W, et.al "A longitudinal study of iron status during pregnancy and the risk of gestational diabetes: findings from a prospective, multiracial cohort." Diabetologia 60 (2017): 249-57
  6. Scholl TO, Reilly T "Anemia, Iron and Pregnancy Outcome." J Nutr 130 (2000): 443S-7S
  7. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

References for breastfeeding information

  1. Allen LH "Multiple micronutrients in pregnancy and lactation: an overview." Am J Clin Nutr 81(S) (2005): 1206S-12S
  2. NIH Office of Dietary Supplements "Iron Dietary Supplement Fact Sheet. Available from: URL: https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/?print=1" ([2016, Feb 01]):
  3. Picciano MF "Pregnancy and Lactation: Physiological Adjustments, Nutritional Requirements and the Role of Dietary Supplements." J Nutr 133 (2003): 1997S-2002S
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide